Assignment of Assignor's Interest

Recorded: 2017-10-24 Pages: 16

Assignor

UCB PHARMA, S.A.

Executed: 2015-12-08

Assignee

UCB BIOPHARMA SPRL

60 ALLEE DE LA RECHERCHE, BRUSSELS, B-1070, BELGIUM

Covered Property (1)

Dual Specificity Antibody Fusions

Patent: 9,828,438 →

Application: 15/058,460 →

Publication: US 2016/0311930

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.